TrialNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2016

5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder.

Pedro E Martinez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.